Citations to this article

Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones, … , Jürgen Scheller, Stefan Rose-John
Simon A. Jones, … , Jürgen Scheller, Stefan Rose-John
Published September 1, 2011
Citation Information: J Clin Invest. 2011;121(9):3375-3383. https://doi.org/10.1172/JCI57158.
View: Text | PDF
Science in Medicine Article has an altmetric score of 23

Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling

Abstract

The successful treatment of certain autoimmune conditions with the humanized anti–IL-6 receptor (IL-6R) antibody tocilizumab has emphasized the clinical importance of cytokines that signal through the β-receptor subunit glycoprotein 130 (gp130). In this Review, we explore how gp130 signaling controls disease progression and examine why IL-6 has a special role among these cytokines as an inflammatory regulator. Attention will be given to the role of the soluble IL-6R, and we will provide a perspective into the clinical blockade of IL-6 activity in autoimmunity, inflammation, and cancer.

Authors

Simon A. Jones, Jürgen Scheller, Stefan Rose-John

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 Total
Citations: 7 10 10 29 33 27 21 21 35 24 28 25 29 19 1 1 320
Citation information

Citations to this article in year 2015 (28)

Title and authors Publication Year
IL-6 as a keystone cytokine in health and disease
CA Hunter, SA Jones 		Nature Immunology 2015
IL-6 Trans-Signaling Drives Murine Crescentic GN
GS Braun, Y Nagayama, Y Maruta, F Heymann, CR van Roeyen, BM Klinkhammer, P Boor, L Villa, DJ Salant, U Raffetseder, S Rose-John, T Ostendorf, J Floege 		Journal of the American Society of Nephrology : JASN 2015
The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
AH Koeppen, RL Ramirez, AB Becker, ST Bjork, S Levi, P Santambrogio, PJ Parsons, PC Kruger, KX Yang, PJ Feustel, JE Mazurkiewicz, K Pantopoulos 		PloS one 2015
The Role of the Transcriptional Regulation of Stromal Cells in Chronic Inflammation
A Valin, J Pablos 		Biomolecules 2015
IL-6 Plays a Crucial Role in HBV Infection
T Lan, L Chang, L Wu, YF Yuan 		Journal of Clinical and Translational Hepatology 2015
Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation
S Sindhu, R Thomas, P Shihab, D Sriraman, K Behbehani, R Ahmad, CM Stover 		PloS one 2015
Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells
W Cao, Y Liu, R Zhang, B Zhang, T Wang, X Zhu, L Mei, H Chen, H Zhang, P Ming, L Huang 		Scientific Reports 2015
The unusual suspects—innate lymphoid cells as novel therapeutic targets in IBD
R Goldberg, N Prescott, GM Lord, TT MacDonald, N Powell 		Nature Reviews Gastroenterology & Hepatology 2015
Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model
M Hatting, M Spannbauer, J Peng, MA Masaoudi, G Sellge, YA Nevzorova, N Gassler, C Liedtke, FJ Cubero, C Trautwein 		Cell Death and Disease 2015
Emerging cytokine networks in colorectal cancer
NR West, S McCuaig, F Franchini, F Powrie 		Nature Reviews Immunology 2015
The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development
WW Lin, Z Yi, LL Stunz, CJ Maine, LA Sherman, GA Bishop 		Science signaling 2015
Using gene therapy to manipulate the immune system in the fight against B-cell leukemias
DC Bouhassira, JJ Thompson, ML Davila 		Expert Opinion on Biological Therapy 2015
Immunosuppressive effects of Amblyomma cajennense tick saliva on murine bone marrow-derived dendritic cells
TM Carvalho-Costa, MT Mendes, MV da Silva, TA da Costa, MG Tiburcio, AC Anhê, V Rodrigues, CJ Oliveira 		Parasites & vectors 2015
Nickel Ions Selectively Inhibit Lipopolysaccharide-Induced Interleukin-6 Production by Decreasing Its mRNA Stability
S Asakawa, Y Kishimoto, T Takano, K Okita, S Takakuwa, T Sato, M Hiratsuka, O Takeuchi, N Hirasawa, P Proost 		PloS one 2015
Loss of the Polarity Protein PAR3 Activates STAT3 Signaling via an Atypical Protein Kinase C (aPKC)/NF-κB/Interleukin-6 (IL-6) Axis in Mouse Mammary Cells
RA Guyer, IG Macara 		The Journal of biological chemistry 2015
Rheumatoid arthritis: IL-6 inhibition in RA—déjà vu all over again?
EM Ruderman 		Nature Reviews Rheumatology 2015
Inhibition of IL-6 Signaling Pathway by Curcumin in Uterine Decidual Cells
YS Devi, M DeVine, J DeKuiper, S Ferguson, AT Fazleabas, A Croy 		PloS one 2015
Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN
M Luig, MA Kluger, B Goerke, M Meyer, A Nosko, I Yan, J Scheller, HW Mittrucker, S Rose-John, RA Stahl, U Panzer, OM Steinmetz 		Journal of the American Society of Nephrology : JASN 2015
Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer
C Bilir, H Engin, M Can, S Likhan, D Demirtas, F Kuzu, T Bayraktaroglu 		Oncology Letters 2015
Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells
B Trinschek, F Luessi, C Gross, H Wiendl, H Jonuleit 		International journal of molecular sciences 2015
HCS Campaign to Identify Selective Inhibitors of IL-6-Induced STAT3 Pathway Activation in Head and Neck Cancer Cell Lines
PA Johnston, M Sen, Y Hua, DP Camarco, TY Shun, JS Lazo, GM Wilson, LO Resnick, MG LaPorte, P Wipf, DM Huryn, JR Grandis 		ASSAY and Drug Development Technologies 2015
Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies
BD Paepe, J Zschüntzsch 		International journal of molecular sciences 2015
Inflammation in acute and chronic pancreatitis:
A Habtezion 		Current Opinion in Gastroenterology 2015
IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis
AE Anderson, AG Pratt, MA Sedhom, JP Doran, C Routledge, B Hargreaves, PM Brown, KA Cao, JD Isaacs, R Thomas 		Annals of the rheumatic diseases 2015
Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis
Q Fu, Y Chang, H An, H Fu, Y Zhu, L Xu, W Zhang, J Xu 		British Journal of Cancer 2015
Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer
R Bharti, G Dey, PK Ojha, S Rajput, SK Jaganathan, R Sen, M Mandal 		Oncogene 2015
Prognostic and clinicopathological significance of serum interleukin-6 expression in colorectal cancer: a systematic review and meta-analysis
Z Wang, P Wu, D Wu, Z Zhang, G Hu, Y Lai, J Huang, S Zhao 		OncoTargets and therapy 2015
A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
Zhao H, Guo Y, Li S, Han R, Ying J, Zhu H, Wang Y, Yin L, Han Y, Sun L, Wang Z, Lin Q, Bi X, Jiao Y, Jia H, Zhao J, Huang Z, Li Z, Zhou J, Song W, Meng K, Cai J 		Oncotarget 2015

Advertisement